Impact of strategies and activities for reducing morbidity and mortality of vaccine-preventable diseases in Oman: A status report
Journal Title: Journal of Vaccines & Immunization - Year 2015, Vol 3, Issue 1
Abstract
Immunization is the only child survival strategy which alone averts two to three million deaths each year. This has been possible because of high coverages achieved by many countries in the world. Still nearly 1.5 million children die of vaccine preventable diseases each year, mainly because of poor uptake of vaccines particularly in developing and under-developed countries. This calls for a detailed review and study of the successful models in countries which have consistently achieved high immunization coverage. Oman is one of those countries which has maintained more than 95% immunization coverage for more than a decade. The outcome has been that in Oman the incidence of vaccine preventable diseases has continued to remain low. The three major pillars behind the success of the immunization programme in Oman have been national expended programme of immunization, surveillance network and efficient supply chain system.
Authors and Affiliations
Al Awaidy ST
Keywords
Related Articles
- EP ID EP566660
- DOI 10.14312/2053-1273.2015-1
- Views 47
- Downloads 0
Influenza and pneumococcal vaccination in hospitalized adults with pandemic (H1N1) 2009: Immunization practices and impact on clinical presentation and outcomes
The purpose of this study was to determine vaccination rates against influenza and pneumococcus in a large cohort of adults hospitalized with confirmed influenza A(H1N1) pdm09 infection, and to identify differences in cl...
Silk-based microneedle transdermal immunization with EV71 vaccines elicits potent immune responses in mice
Hand, foot, and mouth disease (HFMD), caused by EV71 viral infection, has emerged as a serious public health concern in the Asia-Pacific region. The lack of effective treatment has led to a focus on controlling EV71 epid...
Immunogenicity of 13-valent pneumococcal conjugate vaccine in immunocompetent older adults with stable underlying medical conditions
The 13-valent pneumococcal conjugate vaccine (PCV13) elicits robust functional antibody responses in immunocompetent adults aged ≥50 years, including healthy adults and those considered at risk (ie, stable, chronic cardi...
An evaluation of the indirect cohort method to estimate the effectiveness of the pneumococcal polysaccharide vaccine
We examined the validity of the indirect cohort method as a rapid assessment tool to estimate pneumococcal polysaccharide vaccine effectiveness (VE). Using evidence from published clinical trials, we reviewed the primary...
Impact of strategies and activities for reducing morbidity and mortality of vaccine-preventable diseases in Oman: A status report
Immunization is the only child survival strategy which alone averts two to three million deaths each year. This has been possible because of high coverages achieved by many countries in the world. Still nearly 1.5 millio...